Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
4182232 | L'Encéphale | 2009 | 9 Pages |
Abstract
In practice, clozapine seems to be efficient in bipolar disorders, although the marketing authorisation does not envisage this indication. It is never prescribed first, as some recommendations indicate, even though the follow-up of certain treatments does not always seem adequate to appreciate their non-effectiveness. Seldom prescribed alone, clozapine is often associated with another antipsychotic, a practice not favoured by many experts. Our investigation thus confirms the increase in co-prescriptions, particularly in hospital, for patients who have not improved with clozapine alone, a case that is barely taken into consideration in consensus conferences. With the lack of innovative molecules, psychiatrists are prompted to associate several antipsychotics, with the risk of supporting iatrogenic medication, whereas the experts reserve the relevance of such associations because of a lack of randomised studies.
Related Topics
Health Sciences
Medicine and Dentistry
Psychiatry and Mental Health
Authors
C. Mercier, P. Bret, M.-C. Bret, E. Queuille,